Real-time enrollment status for this hidradenitis suppurativa clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT05889182 |
| Recruiting Status | Recruiting |
| Condition | Hidradenitis Suppurativa |
| Phase | Clinical Trial |
| Target Enrollment | 1,328 participants |
| Active Locations | 84 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | December 2, 2025 (Dec 2, 2025) |
As of March 2, 2026: Clinical trial NCT05889182 is currently recruiting participants. This clinical trial study for hidradenitis suppurativa is actively seeking new participants at 84 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05889182 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 84 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05889182 was last updated Dec 2, 2025 (December 2, 2025). HelloStudys verifies this status automatically.